Abbott analysers in UK false negatives alert:
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has reported problems with Abbott Diagnostics' AxSYM and AxSYM Plus laboratory analysers. Three unrepeatable false negative results have been reported at one UK centre using an HIV assay on the AxSYM Plus analyser, the agency said in an alert dated July 13. At another centre, four unrepeatable false negative results have been reported involving a rubella IgG assay on an AxSYM system. Initial investigations suggest three potential causes: a blocked process probe, unrecovered probe crashes or the wrong sample tubes.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.